| Literature DB >> 28126001 |
Joseph Biggs1, Jaishree Raman2,3,4, Jackie Cook5, Khumbulani Hlongwana6, Chris Drakeley1, Natashia Morris7, Ishen Serocharan7, Eunice Agubuzo8,9, Philip Kruger10, Aaron Mabuza11, Alpheus Zitha11, Elliot Machaba10, Maureen Coetzee8,9, Immo Kleinschmidt9,5.
Abstract
BACKGROUND: It is widely acknowledged that modifications to existing control interventions are required if South Africa is to achieve malaria elimination. Targeting indoor residual spraying (IRS) to areas where cases have been detected is one strategy currently under investigation in northeastern South Africa. This seroprevalence baseline study, nested within a targeted IRS trial, was undertaken to provide insights into malaria transmission dynamics in South Africa and evaluate whether sero-epidemiological practices have the potential to be routinely incorporated into elimination programmes.Entities:
Keywords: Elimination; Heterogeneity; Hotspot; Malaria; PfAMA-1; PfMSP-119; Serology; South Africa; Transmission
Mesh:
Year: 2017 PMID: 28126001 PMCID: PMC5270351 DOI: 10.1186/s12936-017-1701-7
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Fig. 1Location of the study sites situated within the municipalities of Ba-Phalaborwa and Bushbuckridge in northeastern South Africa. Passively reported malaria incidence data was obtained from health facilities between 2010 and 2015 then averaged among study site wards [43]
Demographic characteristics and risk factors associated with P. falciparum seroprevalence
| Risk factor | Total |
| Unadjusted | Adjusted | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| %n | n | %n | n | %n 95% CI | ORa | 95% CI |
| ORb | 95% CI | p-value | |
| Age (years) | |||||||||||
| 2–5 | 8.8 | 394 | 4.6 | 18 | 2.9–7.1 | 0.21 | 0.12–0.35 | <0.001 | 0.22 | 0.13–0.38 | <0.001 |
| 6–15 | 10.7 | 481 | 10 | 48 | 7.6–13.0 | 0.48 | 0.34–0.69 | <0.001 | 0.52 | 0.36–0.75 | 0.001 |
| 16–40 | 45.8 | 2050 | 12.8 | 263 | 11.5–14.4 | 0.71 | 0.58–0.88 | 0.002 | 0.71 | 0.58–0.89 | 0.002 |
| ≥ 41 | 34.7 | 1552 | 17.1 | 266 | 15.4–19.1 | 1 | 1 | ||||
| Gender | |||||||||||
| Male | 30.3 | 1357 | 10.7 | 145 | 9.2–12.4 | 0.67 | 0.54–0.84 | <0.001 | 0.77 | 0.62–0.97 | 0.057 |
| Female | 69.7 | 3120 | 14.4 | 450 | 13.2–15.7 | 1 | 1 | ||||
| Education status | |||||||||||
| Primary and below | 49.5 | 2218 | 13.6 | 302 | 12.3–15.1 | 1 | 1 | ||||
| Secondary and above | 50.5 | 2259 | 13 | 293 | 11.7–14.4 | 0.89 | 0.73–1.08 | 0.239 | 0.72 | 0.56–0.95 | 0.018 |
| Employment status | |||||||||||
| Unemployment | 86.7 | 3881 | 13.1 | 508 | 12.1–14.2 | 0.36 | 0.11–1.19 | 0.094 | |||
| Some employment | 0.5 | 21 | 19.1 | 4 | 7.67–40.0 | 1 | |||||
| Full employment | 12.8 | 575 | 14.4 | 83 | 11.8–17.5 | 0.42 | 0.12–1.44 | 0.168 | |||
| Household IRS between Aug 2014 and Feb 2015 | |||||||||||
| Yes | 45.4 | 2034 | 11.8 | 239 | 10.4–13.2 | 0.93 | 0.73–1.18 | 0.537 | |||
| No | 53.1 | 2375 | 14.8 | 351 | 13.4–16.3 | 1 | |||||
| Not sure | 1.5 | 68 | 7.4 | 5 | 3.18–16.1 | 1.05 | 0.40–2.81 | 0.916 | |||
| Travel outside S. Africa in the past 6 months | |||||||||||
| Yes | 1.5 | 65 | 21.5 | 14 | 13.3–33.0 | 1 | |||||
| No | 98.5 | 4412 | 13.2 | 581 | 12.2–14.2 | 0.63 | 0.31–1.26 | 0.190 | |||
| Outdoor nightime activity last night | |||||||||||
| Yes | 21.1 | 945 | 12.4 | 117 | 10.4–14.6 | 1 | |||||
| No | 78.9 | 3532 | 13.5 | 478 | 12.4–14.7 | 0.90 | 0.68–1.19 | 0.464 | |||
| Household elevation (m) | |||||||||||
| 350–450 | 41.4 | 1855 | 9.1 | 168 | 7.8–10.5 | 0.57 | 0.32–0.99 | 0.057 | |||
| 451–550 | 18.3 | 818 | 18.1 | 148 | 15.6–20.9 | 1 | |||||
| 551–650 | 29.0 | 1296 | 18.1 | 235 | 16.1–20.3 | 1.06 | 0.64–1.77 | 0.823 | |||
| 651–750 | 11.4 | 508 | 8.7 | 44 | 6.5–11.4 | 1.01 | 0.49–2.08 | 0.969 | |||
| Study site | |||||||||||
| Ba-Phalaborwa | 35.3 | 1580 | 6.8 | 107 | 5.6–8.1 | 0.23 | 0.09–0.63 | 0.004 | 0.26 | 0.10–0.74 | 0.012 |
| Bushbuckridge | 64.7 | 2897 | 16.9 | 488 | 15.5–18.2 | 1 | 1 | ||||
| Total | 100 | 4477 | 13.3 | 595 | 12.3–14.3 | ||||||
Seropositivity to either PfAMA-1 and/or PfMSP-119 across the study sites of Ba-Phalaborwa and Bushbuckridge. Individual level data: age, gender, education status and employment status. Household level data: household IRS between August 2014 and February 2015, travel outside South Africa in the past 6 months, outdoor activity last night and household elevation
aAdjusted for correlation at the study ward level
bAdjusted for Age, gender, study site and correlation at the study ward level
Fig. 2Plasmodium falciparum age-seroprevalence curves for the entire study site (a) and distinct geographical regions within each study site (b, c). Seroprevalence curves, fitted by maximum likelihood, represent the average annual rate at which this population become seropositive to either PfAMA-1 and/or PfMSP-119 characterized by a seroconversion rate (SCR). Red triangles: observed age-seroprevalence, solid lines: predicted seroprevalence and dotted lines: predicted seroprevalence upper and lower 95% confidence intervals. N: sample size
Fig. 3Spatial analyses of household P. falciparum seroprevalance across the Ba-Phalaborwa and Bushbuckridge study sites. a Spatial distribution of households containing ≥1 PfAMA-1 and/or PfMSP-119 seropositive individual(s). SaTScan™ derived statistically significant (p-values <0.05) clusters of seropositive households reveal regions where there are a higher number of seropositive households than expected. b Spatial distribution of households containing ≥1 PfAMA-1 and/or PfMSP-119 seropositive individual(s) aged 5 years and under
Fig. 4Spatial analyses of household-averaged, age-adjusted antibody responses to PfAMA-1 (a) and PfMSP-119 (b) across the Ba-Phalaborwa and Bushbuckridge study sites. Age-adjusted antibody responses were derived from log-transformed PfAMA-1/PfMSP-119 normalized OD values adjusted at 30 years. The resultant residual values were categorized as: as ‘lower than average’ (−2.370 to −0.499), ‘average’ (−0.500 to 0.500), ‘slightly higher than average’ (0.501–1.250), ‘higher than average’ (1.251–2.000) and ‘much higher than average’ (2.001–2.936). Statistically significant clusters (p-values < 0.05) of higher than average age-adjusted PfAMA-1/PfMSP-119 antibody responses are also shown
Fig. 5Scatter plot of average reported malaria incidence per study ward between 2010 and 2015 and average study ward elevation. Elevation in metres from sea level. Slope: −0.006, r: −0.58
Fig. 6Scatter plot of average reported malaria incidence per study ward between 2010 and 2015 and study ward seroprevalence. Ward-level seroprevalence corresponds to the percentage of sampled seropositive households in each ward